Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1/2 1

Status

Active not recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Myeloid 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 394Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Hematologic Neoplasms 206Leukemia, Lymphocytic, Chronic, B-Cell 175Myelodysplastic Syndromes 144Leukemia 125Lymphoma 90Lymphoma, Non-Hodgkin 76Multiple Myeloma 67Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Recurrence 55Neoplasms 53Leukemia, Myelomonocytic, Chronic 50Burkitt Lymphoma 44Lymphoma, Large B-Cell, Diffuse 41Leukemia, Biphenotypic, Acute 41Myeloproliferative Disorders 39Lymphoma, Mantle-Cell 39Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 37Hodgkin Disease 36Lymphoma, B-Cell 32Lymphoma, Follicular 31Leukemia, B-Cell 27Lymphoma, B-Cell, Marginal Zone 24Anemia, Refractory, with Excess of Blasts 24Waldenstrom Macroglobulinemia 23Primary Myelofibrosis 21Myelodysplastic-Myeloproliferative Diseases 20Hematologic Diseases 19Lymphoma, T-Cell 16

Interventions

nilotinib 2asciminib 2fludarabine 1bosutinib 1Imatinib Mesylate 1Dasatinib 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Philadelphia Chromosome × Other hematologic neoplasm × 90 days × Clear all
NCT04971226 2026-06-05

A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP

Novartis

Phase 3 Active not recruiting
405 enrolled 18 charts 1 FDA
MyeloidOther hematologic neoplasm

Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT05442515 2026-05-28

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
130 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Non-Hodgkin, Philadelphia Chromosome, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05456191 2026-05-27

ASC4START

Novartis

Phase 3 Active not recruiting
568 enrolled 11 charts
MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡